article · Scientific Reports
SNHG3 and LUNAR1 might be useful non-invasive bio-molecular markers for CRC monitoring. Being correlated with poorer CRC patients' clinical features, SNHG3 and LUNAR1 lncRNAs might constitute potential putative therapeutic targets for CRC, per identified downstream genes or proteins in silico, a step toward ncRNA-based precision medicine.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.1038/s41598-026-37432-y
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.
